Related Experiment Video
Updated: Jul 19, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management
1Interstitial Lung Disease Center, San Francisco General Hospital, San Francisco, CA 94110, USA. tking@medsfgh.ucsf.edu
Transactions of the American Clinical and Climatological Association
|October 25, 2006
Summary
Idiopathic interstitial pneumonias are complex lung diseases. Identifying usual interstitial pneumonia, common in idiopathic pulmonary fibrosis, is crucial for better treatment and prognosis.
Area of Science:
- Pulmonology
- Pathology
- Radiology
Background:
- Idiopathic interstitial pneumonias (IIPs) represent a poorly understood, heterogeneous group of lung diseases.
- Clinical-radiological-pathological classification is vital for understanding IIP pathogenesis, treatment, and prognosis.
- Distinguishing usual interstitial pneumonia (UIP), the hallmark of idiopathic pulmonary fibrosis (IPF), is critical due to its poorer outcomes.
Purpose of the Study:
- To emphasize the importance of a structured clinical-radiological-pathological approach in diagnosing IIPs.
- To highlight the critical distinction of usual interstitial pneumonia (UIP) in the context of idiopathic pulmonary fibrosis (IPF).
- To underscore the implications of accurate diagnosis for therapy, prognostication, and future research.
Main Methods:
- Review and synthesis of current clinical, radiological, and pathological criteria for IIP classification.
- Emphasis on the diagnostic role of surgical lung biopsy when clinical and radiographic findings are indeterminate.
- Focus on differentiating UIP from other IIP subtypes.
Main Results:
- Subclassification of IIPs reveals significant differences in pathogenesis, treatment response, and prognosis.
- Idiopathic pulmonary fibrosis (IPF), characterized by UIP, demonstrates a worse prognosis and therapeutic response.
- Understanding UIP as a fibroproliferative process opens avenues for antifibrotic therapies.
Conclusions:
- A structured diagnostic approach integrating clinical, radiological, and pathological data is essential for managing IIPs.
- Accurate identification of idiopathic pulmonary fibrosis (IPF) through UIP recognition improves patient care and outcomes.
- Further research into the distinct pathophysiology of UIP is necessary for developing targeted antifibrotic therapies.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...